Asthma outcomes: Biomarkers
Section snippets
Summary
- •
Atopic status is an important phenotype and should be documented in clinical research studies to permit adequate interpretation of study findings. The presence of allergen-specific IgE is a biomarker for atopic asthma.
- •
The multiallergen screen is a single semiquantitative serologic measure of IgE against major allergens. It is considered a core biomarker that permits characterization of the atopic status of a study population in prospective clinical trials and observational studies. It
Cortisol
Cortisol measures can be used in the following ways:
- •
Cortisol suppression measures are used primarily as a biomarker to assess inhaled or systemic corticosteroids with respect to the level of systemic exposure and their effect on the hypothalamic-pituitary-adrenal axis.
- •
Measurement of cortisol levels (particularly 12-hour overnight or 24-hour plasma cortisol) should be considered for the characterization and definition of the therapeutic index of new corticosteroids (asthma effect-to-systemic
Biospecimen acquisition and storage for detection of biomarkers
Most clinical trials archive biospecimens for genetics and genomics (eg, transcriptomics, proteomics, lipomics, and metabolomics); however, the stability of the biospecimens over extended periods remains unclear. Generally, storage at −80°C immediately upon acquisition confers the greatest stability. Evidence suggests that samples obtained from study participants with asthma are more susceptible to degradation than those obtained from control participants.165, 166 Peripheral blood, the most
Priority questions for future research
- 1.
Can exhaled NO best be used as a unique marker of inflammation to predict and monitor response to asthma treatment?
- 2.
Do differences in sputum processing significantly affect the utility of sputum eosinophils to guide anti-inflammatory therapy?
- 3.
Can a simpler surrogate for sputum eosinophils be developed?
- 4.
Will characterization of asthma by atopic status contribute to a better understanding and differentiation of asthma phenotypes?
- 5.
What is the relationship between measures of cortisol suppression and
References (173)
- et al.
Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests
Lancet
(1975) - et al.
Early identification of atopy in the prediction of persistent asthma in children
Lancet
(2008) - et al.
IgE antibody quantification and the probability of wheeze in preschool children
J Allergy Clin Immunol
(2005) Clinical laboratory assessment of immediate-type hypersensitivity
J Allergy Clin Immunol
(2010)- et al.
A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy
J Allergy Clin Immunol
(1999) - et al.
Efficacy of a single diagnostic test for sensitization to common inhalant allergens
Ann Allergy Asthma Immunol
(2001) - et al.
The reproducibility of the allergy skin test scoring and interpretation by board-certified/board-eligible allergists
Ann Allergy Asthma Immunol
(2002) Accuracy of US Food and Drug Administration-cleared IgE antibody assays in the presence of anti-IgE (omalizumab)
J Allergy Clin Immunol
(2006)- et al.
Distribution of IgE in a community population sample: correlations with age, sex, and allergen skin test reactivity
J Allergy Clin Immunol
(1981) - et al.
Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers
Chest
(2007)
Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height
Respir Med
Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years
J Allergy Clin Immunol
Exhaled nitric oxide predicts exercise-induced bronchoconstriction in asthmatic school children
Chest
Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children
Chest
Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample
Chest
Short-term variability of exhaled nitric oxide in young male patients with mild asthma and in healthy subjects
Respir Med
Significant variability in response to inhaled corticosteroids for persistent asthma
J Allergy Clin Immunol
Atopy influences exhaled nitric oxide levels in adult asthmatics
Chest
Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults
J Allergy Clin Immunol
Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma
J Allergy Clin Immunol
Non-eosinophilic corticosteroid unresponsive asthma
Lancet
Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation
J Allergy Clin Immunol
Analysis of induced sputum after air and ozone exposures in healthy subjects
Environ Res
Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects
J Allergy Clin Immunol
Use of induced sputum to examine airway inflammation in childhood asthma
J Allergy Clin Immunol
Induced sputum and response to glucocorticoids
J Allergy Clin Immunol
Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children–1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999
Am J Respir Crit Care Med
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005
Am J Respir Crit Care Med
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications
Am J Respir Crit Care Med
Quality of care for childhood asthma: estimating impact and implications
Pediatrics
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice
Am J Respir Crit Care Med
Asthma pathogenesis
Measurement of specific IgE antibodies in nasal secretion–evidence for local production
Clin Allergy
Local specific IgE production in nasal polyps associated with negative skin tests and serum RAST
Ann Allergy
Mucosal allergy in the absence of systemic allergy in nasal polyposis and rhinitis: a meta-analysis
Otolaryngol Head Neck Surg
A quantitative analysis of cedar pollen-specific immunoglobulins in nasal lavage supported the local production of specific IgE, not of specific IgG
Microbiol Immunol
The relationship between parental and children’s serum IgE and asthma
Am J Respir Crit Care Med
Longitudinal evaluation of the association between pulmonary function and total serum IgE
Am J Respir Crit Care Med
Association of asthma with serum IgE levels and skin-test reactivity to allergens
N Engl J Med
Human immunoglobulins
Analytical performance characteristics and clinical utility of immunological assays for human immunoglobulin E (IgE) antibody and defined allergen specificities
Quantification of IgE antibodies simplifies the classification of allergic diseases in 4-year-old children. A report from the prospective birth cohort study–BAMSE
Pediatr Allergy Immunol
Quantitative analysis of IgE antibodies to food and inhalant allergens in 4-year-old children reflects their likelihood of allergic disease
Allergy
Proficiency survey-based evaluation of clinical total and allergen-specific IgE assay performance
Arch Pathol Lab Med
Phadiatop compared to skin-prick test as a tool for diagnosing atopy in epidemiological studies in schoolchildren
Pediatr Allergy Immunol
Accuracy of ImmunoCAP Rapid in the diagnosis of allergic sensitization in children between 1 and 14 years with recurrent wheezing: the IReNE study
Pediatr Allergy Immunol
Phadiatop infant in the diagnosis of atopy in children with allergy-like symptoms
Int J Pediatr
In vivo effects of glucocorticoids on IgE production
J Allergy Clin Immunol
Hydrocortisone and IL-4 induce IgE isotype switching in human B cells
J Immunol
Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children
N Engl J Med
Cited by (321)
Long-term ozone exposure and lung function in middle childhood
2024, Environmental ResearchEosinophilic and noneosinophilic asthma: Beyond severe asthma
2023, Asthma in the 21st Century: New Research AdvancesRethinking blood eosinophil counts: Epidemiology, associated chronic diseases, and increased risks of cardiovascular disease
2022, Journal of Allergy and Clinical Immunology: GlobalAsthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures
2022, Journal of Allergy and Clinical Immunology: In PracticeAsthma Diagnostics, Testing and Treatment
2022, Encyclopedia of Infection and Immunity
The Asthma Outcomes workshop was funded by contributions from the National Institute of Allergy and Infectious Diseases; the National Heart, Lung, and Blood Institute; the Eunice Kennedy Shriver National Institute of Child Health and Human Development; the National Institute of Environmental Health Sciences; the Agency for Healthcare Research and Quality; and the Merck Childhood Asthma Network, as well as by a grant from the Robert Wood Johnson Foundation. Contributions from the National Heart, Lung, and Blood Institute; the National Institute of Allergy and Infectious Diseases; the Eunice Kennedy Shriver National Institute of Child Health and Human Development; the National Institute of Environmental Health Sciences; and the US Environmental Protection Agency funded the publication of this article and all other articles in this supplement.
Disclosure of potential conflict of interest: S. J. Szefler is a consultant for GlaxoSmithKline, Genentech, Merck, Boehringer-Ingelheim, Novartis, and Schering-Plough; and has received research support from the NIH (NHLBI, NIAID, NIEHS) and the Environmental Protection Agency. J. V. Fahy is on the Cytokinetics Scientific advisory board; has received consulting fees from Amgen, Gilcad, Five Prime Therapeutics, Merck, Regeneron Pharmaceuticals, Portola Pharmaceuticals; and has received research support from the NIH (NHLBI and NIAID) and Genentech. J. F. Hunt is on the Pulse Health LLC advisory board; is founder of Respiratory Research, Inc; has received research support from the NIH-NIAID and Altrea; and is Chair of the AAAAI Asthma Diagnosis and Pharmacotherapeutics Committee and Cough Committee. A. H. Liu has received speaker honoraria from Merck; is on the Data Safety Monitoring Board for GlaxoSmithKline; and is a consultant for DBV. R. A. Panettieri, Jr, is a consultant for Johnson & Johnson, Forest Pharmaceuticals, Genentech, and Merck; and has received research support from AstraZeneca, Johnson & Johnson, Merck, and Roche. R. P. Schleimer is a consultant for GlaxoSmithKline and Intersect ENT. The rest of the authors declare that they have no relevant conflicts of interest.